Release 4B R5 Final QA

This page is part of the FHIR Specification (v4.3.0: R4B (v5.0.0-draft-final: Final QA Preview for R5 - STU see ballot notes ). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

Substance-example-amoxicillin-clavulanate

Example Substance/f205 (Narrative)

Orders Biomedical Research and Observations Regulation Work Group Maturity Level : N/A Standards Status : Informative Compartments : Not linked to any defined compartments

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile Substance .

Generated Narrative Narrative: Substance

Resource Substance "f205"

instance : false

category : Drug or Medicament ( Substance Category Codes #drug)

Codes

- code : Concept
* Amoxicillin + clavulanate potassium 875mg/125mg tablet (product) ( SNOMED CT #392259005)

description : Augmentin 875

ingredient

quantity : 875 mg (Details: UCUM code mg = 'mg') /1000 mg (Details: UCUM code mg = 'mg')

substance :

Resource "ingr1"

code instance : false

Codes

- Concept
* Amoxicillin (substance) ( SNOMED CT #372687004)

ingredient

quantity : 125 mg (Details: UCUM code mg = 'mg') /1000 mg (Details: UCUM code mg = 'mg')

substance :

Resource "ingr2"

code instance : false

Codes

- Concept
* Clavulanate potassium (substance) ( SNOMED CT #395938000)

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.